Administrative Order No. 2020-0017 || Revised Guidelines on the Unified Licensing Requirements and Procedures of the Food and Drug Administration Repealing Administrative Order No. 2016-0003

The objectives for issuing this Administrative Order are as follows:

1. To simplify the requirements and processes for initial, renewal, and variation of License to Operate (LTO) applications; and
2. To re-engineer and streamline FDA’s processes and automate its system in compliance with the provisions of RA 11032 in the maximum prescribed processing time depending on the complexity of the transaction.

Read more:->Administrative Order No.2020-0017